Cefuroxime presentation

Cefuroxime 125 mg/5 mL suspensions

Our October 2026 copy of the NAFDAC Greenbook lists 13 registrations of Cefuroxime 125 mg/5 mL as suspension, from 10 companies with active status. Every claim below is quoted from that dated copy.

Active registrations (10)

• Cefuroxime Oral SuspensionActive
  A4-0677Fidson Healthcare · India
• Cefuroxime SuspensionActive
  A4-100595Swiss Pharma Nigeria · India
• Ceroxim Suspension 125 mg/5 mLActive
  04-6077Ranbaxy Nigeria · India
• Ethiroxime Suspension 125 mgActive
  A4-100462SK Medicines · India
• Exatil Oral SuspensionActive
  B4-2681Exagon Pharmaceuticals · India
• Kadnat SuspensionActive
  A11-100550Kadark Pharmaceuticals · Nigeria
• Ladfield Cefuroxime SuspensionActive
  A4-101327Ladfield Global Resources · India
• Licafur SuspensionActive
  A4-9912Zolon Healthcare · India
• Miraxim SuspensionActive
  B4-5533Miraflash · Nigeria
• Tazofort Oral SuspensionActive
  B4-0531Chinare Ani Pharmaceuticals · India

No longer active in our copy (3)

Statuses quoted as recorded. Listings can lag renewals — confirm the current status on the official Greenbook before acting on these.

• Avrocef Suspension“Expired”
  A11-1094Avro Pharma · Nigeria
• Sefzitil 125 Oral Suspension“Inactive”
  B4-5744Evans Baroque · India
• SKP Cefuroxime Suspension“Expired”
  A11-0976SKP Pharma · Nigeria

Holding a pack? Match the number printed on it against its own line above, then check it in the NAFDAC checker.

← Full Cefuroxime guide: uses, dosage, prices, all brands

This page quotes the public NAFDAC Greenbook as of our dated copy and is a record of registration, not an endorsement or a statement about any physical product. Registration status can change; for decisions that matter, confirm on the official Greenbook.